Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.
Sign Up to like & getrecommendations! Published in 2018 at "Future oncology"
DOI: 10.2217/fon-2017-0597
Abstract: The advent of immune checkpoint inhibitors (PD-1, PD-L1 and CTLA-4) has resulted in unprecedented long-term remissions of unresectable cancers. The efficacy of checkpoint inhibitors was recently demonstrated in gastrointestinal malignancies with mismatch repair deficiencies (dMMR).… read more here.
Keywords: malignancies 2017; 2017 current; gastrointestinal malignancies; upper gastrointestinal ... See more keywords